Latest update April 11th, 2026 12:35 AM
Latest News
- U.S. EXIM Bank signals interest in major Berbice Deep-Water Port project
- Pres. Ali pushes urgent drive to unlock Guyana–T&T economic partnership
- ASL aircraft crashes in Region 8; GDF launches rescue mission
- Seven-year-old Isabella laid to rest
- Iranian delegation lands in Islamabad ahead of ‘make-or-break’ talks
MOH prepares to go to open tender for drugs procurement
– sister Pharmaceutical companies likely to bid at same time
The Ministry of Health (MOH) has been over time been slammed for its method of procuring drugs through a sole agency, the New Guyana Pharmaceutical Corporation. The current procurement method is by selective tendering, which a Cabinet decision in 2008 allowed, by consenting to a waiver of the Tender Board conditions.
It has recently been disclosed, however, that there are new procedures in the making. The MOH is embarking on a new method of acquiring drugs.
For this year, the Tender Board granted its approval for the purchase drugs from the pre-qualified list of suppliers. This permission expired at the end of June. The MOH is now in the process of preparing a tender document that will be put in the public domain, for all suppliers to indicate their interest in supplying drugs to the Ministry.
That document is now in draft stage, and once completed, will be sent to the Tender Board for approval.
Once approved, it will be used as the basis for pre-qualification of suppliers to supply the Ministry with drugs. It is hoped that this document will be ready before the end of this month.
It has been noted that there are two sister pharmaceutical companies, owned by Queens Atlantic Investments, that will be bidding: The New Guyana Pharmaceutical Corporation and sister company Health Care International, which is set to begin business in a few months time.
Share this:
Discover more from Kaieteur News
Subscribe to get the latest posts sent to your email.